IL2 and neoplasm: Since we previously showed that SRT plus targeted ICK elicited immune memory in the MC38/CEA model,13 we combined SRT plus ICK or IL‐2‐Fc therapy to determine the added effect of tumor targeting in the same subcutaneous MC38/CEA mouse model.